COLLEGIUM PHARMACEUTICAL, INC

By person

28 insiders · 194 transactions

There is no salary here to measure against. COLLEGIUM PHARMACEUTICAL, INC's chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Heffernan Michael Thomas

Director

—

$25.73M (43) scheduled

−$25.73M

50,328

0.1546%

$1.71M

−90.9%

Hirsch David

Director

—

$18.08M (4)

−$18.08M

3,116,956

9.57%

$106.13M

−24.6%

Longitude Capital Partners, LLC entity

10% owner

—

$17.34M (2)

−$17.34M

2,321,842

7.13%

$79.06M

−30.1%

Ciaffoni Joseph

President and CEO

—

$16.93M (40) scheduled

−$16.93M

444,867

1.37%

$15.15M

—

Dreyer Scott

EVP & Chief Commercial Officer

—

$11.58M (31) scheduled

−$11.58M

71,770

0.2205%

$2.44M

—

Kuhlmann Shirley R.

EVP and General Counsel

—

$7.72M (19) scheduled

−$7.72M

108,137

0.3322%

$3.68M

—

Tupper Colleen

EVP & Chief Financial Officer

—

$3.39M (11) scheduled

−$3.39M

147,282

0.4524%

$5.01M

+2,004%

Fleming Alison B

EVP & Chief Technical Officer

—

$1.94M (19) scheduled

−$1.94M

143,694

0.4414%

$4.89M

+1,893%

Fallon John A.

Director

—

$1.65M (1) scheduled

−$1.65M

64,634

0.1985%

$2.20M

+2,621%

BOHLIN GAREN G

Director

—

$1.26M (2) scheduled

−$1.26M

71,000

0.2181%

$2.42M

—

Smith Thomas B

EVP and Chief Medical Officer

—

$1.06M (3)

−$1.06M

90,651

0.2784%

$3.09M

+3,493%

Rubric Capital Management LP entity

10% owner

—

$946.25K (1)

−$946.25K

3,132,743

9.62%

$106.67M

−0.8%

Freund John Gordon

Director

—

$746.02K (4)

−$746.02K

1,335,400

4.10%

$45.47M

−68.0%

Dieter David

EVP & General Counsel

—

$716.21K (2) scheduled

−$716.21K

77,071

0.2367%

$2.62M

+733.7%

SANTINI GINO

Director

—

$201.02K (1) scheduled

−$201.02K

112,483

0.3455%

$3.83M

+385.1%

Brannelly Paul

Executive Vice President & CFO

$91.80K (1)

$279.17K (2)

−$187.37K

215,428

0.6617%

$7.34M

+158.4%

Balice-Gordon Rita J.

Director

—

$171.67K (1)

−$171.67K

61,370

0.1885%

$2.09M

—

Lurker Nancy

Director

—

$161.86K (1)

−$161.86K

26,758

0.0822%

$911.11K

—

KANEKO YASUNORI

10% owner

—

2,150,186

6.60%

$73.21M

−27.1%

Skyline Venture Partners V LP entity

10% owner

—

2,149,916

6.60%

$73.20M

−27.1%

Karnani Vikram

President and CEO

—

197,864

0.6078%

$6.74M

+52,523%

Malamut Richard

EVP and Chief Medical Officer

—

130,264

0.4001%

$4.44M

—

Melincoff Gwen A

Director

—

52,468

0.1612%

$1.79M

—

McFarlane Neil F.

Director

—

49,365

0.1516%

$1.68M

—

Paya Carlos V

Director

—

28,323

0.0870%

$964.40K

—

Duke Barry S

See remarks

—

20,087

0.0617%

$683.96K

+241.0%

Glancy Donovan Michael

Director

—

17,482

0.0537%

$595.26K

—

Schroeder Theodore R

Director

—

11,007

0.0338%

$374.79K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

SANTINI GINO

8 Jun 2026

Director

Exercised, kept

8,700

$16.49

$143.46K

Fleming Alison B

18 Nov 2020

Chief Technology Officer

Exercised, kept

16,000

$5.73

$91.68K

Fleming Alison B

2 Apr 2018

Chief Technology Officer

Exercised, kept

3,917

$0.28

$1.10K

Fleming Alison B

2 Apr 2018

Chief Technology Officer

Exercised, kept

4,225

$0.28

$1.18K

Fleming Alison B

25 Oct 2017

Chief Technology Officer

Exercised, kept

1,811

$3.38

$6.12K

Heffernan Michael Thomas

31 Jan 2017

Chairman, President and CEO

Exercised, kept

3,013

$0.48

$1.45K

Show all 194 transactions →

COLLEGIUM PHARMACEUTICAL, INC

By person

Individual transactions

What was left out